🇯🇵 Upasita in Japan

PMDA authorised Upasita on 23 June 2021

Marketing authorisation

PMDA — authorised 23 June 2021

  • Marketing authorisation holder: SANWA KAGAKU KENKYUSHO Co., Ltd.
  • Status: approved

Upasita in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Hematology approved in Japan

Frequently asked questions

Is Upasita approved in Japan?

Yes. PMDA authorised it on 23 June 2021.

Who is the marketing authorisation holder for Upasita in Japan?

SANWA KAGAKU KENKYUSHO Co., Ltd. holds the Japanese marketing authorisation.